Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 617085, 10 pages
http://dx.doi.org/10.1155/2012/617085
Research Article

Elimination of Cancer Stem-Like “Side Population” Cells in Hepatoma Cell Lines by Chinese Herbal Mixture “Tien-Hsien Liquid”

1Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan
2Center of Excellence for Cancer Research, Taipei Medical University, Taipei, Taiwan
3Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
4Department of Surgery, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
5Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan
6Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan
7National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan
8Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan
9Department of Traditional Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan

Received 30 April 2012; Revised 13 August 2012; Accepted 20 August 2012

Academic Editor: Alexandra Deters

Copyright © 2012 Chih-Jung Yao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Ma, K. W. Chan, L. Hu et al., “Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor Cells,” Gastroenterology, vol. 132, no. 7, pp. 2542–2556, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. B. T. Kvinlaug and B. J. P. Huntly, “Targeting cancer stem cells,” Expert Opinion on Therapeutic Targets, vol. 11, no. 7, pp. 915–927, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Wu and B. A. Alman, “Side population cells in human cancers,” Cancer Letters, vol. 268, no. 1, pp. 1–9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Kim, H. Turnquist, J. Jackson et al., “The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells,” Clinical Cancer Research, vol. 8, no. 1, pp. 22–28, 2002. View at Google Scholar · View at Scopus
  5. M. M. Ho, A. V. Ng, S. Lam, and J. Y. Hung, “Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells,” Cancer Research, vol. 67, no. 10, pp. 4827–4833, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Moserle, M. Ghisi, A. Amadori, and S. Indraccolo, “Side population and cancer stem cells: therapeutic implications,” Cancer Letters, vol. 288, no. 1, pp. 1–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Ichikawa, Y. NAkamura, Y. Kashiwada, and B. B. Aggarwal, “Anticancer drugs designed by mother nature: ancient drugs but modern targets,” Current Pharmaceutical Design, vol. 13, no. 33, pp. 3400–3416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. B. Kim, E. Ko, W. Han, I. Shin, S. Y. Park, and D. Y. Non, “Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells,” Planta Medica, vol. 74, no. 14, pp. 1693–1700, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Aguado, A. Carracedo, B. Julien et al., “Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis,” The Journal of Biological Chemistry, vol. 282, no. 9, pp. 6854–6862, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kakarala, D. E. Brenner, H. Korkaya et al., “Targeting breast stem cells with the cancer preventive compounds curcumin and piperine,” Breast Cancer Research and Treatment, vol. 122, no. 3, pp. 777–785, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Sun, J. S. Chia, W. B. Wang, and C. P. Chiang, “"Tien-hsien liquid" can modulate antigen-stimulated cytokine production by t-cells isolated from patients with recurrent aphthous ulcerations,” American Journal of Chinese Medicine, vol. 33, no. 4, pp. 559–571, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C. J. Yao, C. M. Yang, S. E. Chuang et al., “Targeting PML-RARα and oncogenic signaling pathways by Chinese herbal mixture Tien-Hsien liquid in acute promyelocytic leukemia NB4 cells,” Evidence-based Complementary and Alternative Medicine, vol. 2011, Article ID 984154, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. S. Chia, J. L. Du, W. B. Hsu, A. Sun, C. B. Chiang, and W. B. Wang, “Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid,” BMC Cancer, vol. 10, p. 175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. T. L. Lin, C. Fu, and K. M. Sakamoto, “Cancer stem cells: the root of the problem,” Pediatric Research, vol. 62, no. 3, p. 239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. T. C. Chou and P. Talalay, “Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors,” Advances in Enzyme Regulation, vol. 22, no. C, pp. 27–55, 1984. View at Google Scholar · View at Scopus
  16. S. J. Forbes and M. R. Alison, “Side population (SP) cells: taking center stage in regeneration and liver cancer?” Hepatology, vol. 44, no. 1, pp. 23–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Chiba, K. Kita, Y. W. Zheng et al., “Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties,” Hepatology, vol. 44, no. 1, pp. 240–251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Klonisch, E. Wiechec, S. Hombach-Klonisch et al., “Cancer stem cell markers in common cancers—therapeutic implications,” Trends in Molecular Medicine, vol. 14, no. 10, pp. 450–460, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Suetsugu, M. Nagaki, H. Aoki, T. Motohashi, T. Kunisada, and H. Moriwaki, “Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells,” Biochemical and Biophysical Research Communications, vol. 351, no. 4, pp. 820–824, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Wu, Q. Wei, V. Utomo et al., “Side population cells isolated from mesenchymal neoplasms have tumor initiating potential,” Cancer Research, vol. 67, no. 17, pp. 8216–8222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Huangfu and K. V. Anderson, “Signaling from Smo to Ci/Gli: conservation and divergence of Hedgehog pathways from Drosophila to vertebrates,” Development, vol. 133, no. 1, pp. 3–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Yin, J. Li, C. Hu et al., “CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity,” International Journal of Cancer, vol. 120, no. 7, pp. 1444–1450, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. A. A. Merchant and W. Matsui, “Targeting Hedgehog—a cancer stem cell pathway,” Clinical Cancer Research, vol. 16, no. 12, pp. 3130–3140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Feldmann, S. Dhara, V. Fendrich et al., “Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers,” Cancer Research, vol. 67, no. 5, pp. 2187–2196, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. F. H. Sarkar, Y. Li, Z. Wang, and D. Kong, “The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer,” Cancer and Metastasis Reviews, vol. 29, no. 3, pp. 383–394, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Hu, H. Li, J. Li et al., “Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling,” Carcinogenesis, vol. 29, no. 12, pp. 2289–2297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Ma, T. K. Lee, B. J. Zheng, K. W. Chan, and X. Y. Guan, “CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway,” Oncogene, vol. 27, no. 12, pp. 1749–1758, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Wang, S. Huang, L. Yang et al., “Down-regulation of Sonic hedgehog signaling pathway activity is involved in 5-fluorouracil-induced apoptosis and motility inhibition in Hep3B cells,” Acta Biochimica et Biophysica Sinica, vol. 40, no. 9, pp. 819–829, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Oishi and X. W. Wang, “Novel therapeutic strategies for targeting liver cancer stem cells,” International Journal of Biological Sciences, vol. 7, no. 5, pp. 517–535, 2011. View at Google Scholar · View at Scopus
  30. V. Rausch, L. Liu, G. Kallifatidis et al., “Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics,” Cancer Research, vol. 70, no. 12, pp. 5004–5013, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. H.-C. Tsai, H. Li, L. Van Neste et al., “Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells,” Cancer Cell, vol. 21, no. 3, pp. 430–446, 2012. View at Publisher · View at Google Scholar · View at Scopus